Comparison the therapeutic efficacy of Cimetidine and Cryotherapy in treatment of warts

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201008134128N2

Enrollment

Registered

2010-09-09

Start date

2007-04-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases of the skin and subcutaneous tissue - Wart. Viral infections characterized by skin and mucous membrane lesions

Interventions

Intervention 1: First group: Cimetidine, 40 mg/kg daily for three months, also their warts were freezed monthly for three months. Intervention 2: Second group: placebo and their warts were freezed mon

Treatment - Drugs

Placebo

First group: Cimetidine, 40 mg/kg daily for three months, also their warts were freezed monthly for three months

Second group: placebo and their warts were freezed monthly for three month

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patient with common wart. Exclusion criteria: Raynaud’s Phenomen, peripheral vascular disease, previous wart treatment and cold urticaria.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Cilinical improvment. Timepoint: 1 month. Method of measurement: cilinical observation.	—

Secondary

Measure	Time frame
Treatment compilications and relapse. Timepoint: Monthly for 3 month. Method of measurement: cilinical observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMajid Rostami Mogaddam

Ardebil university of medical sciences

m.rostami@arums.ir , drrostami@yahoo.com+98 45 1224 6687

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026